These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 9838474)
1. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506. Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474 [No Abstract] [Full Text] [Related]
2. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214 [No Abstract] [Full Text] [Related]
3. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335 [No Abstract] [Full Text] [Related]
4. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy. Crespo-Leiro MG; Paniagua MJ; Mosquera I; Tabuyo T; De la Fuente L; Bouzas B; Rodriguez JA; Hermida LF; Juffé A; Castro-Beiras A Transplant Proc; 2002 Feb; 34(1):113-4. PubMed ID: 11959213 [No Abstract] [Full Text] [Related]
5. Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. Taibi A; Adham M; Ducerf C; Chevallier M; Bizollon T; Delaroche E; Aljuaid N; Berthoux N; Baulieux J Transplant Proc; 1998 Jun; 30(4):1411-2. PubMed ID: 9636571 [No Abstract] [Full Text] [Related]
6. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254 [TBL] [Abstract][Full Text] [Related]
7. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A. Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333 [No Abstract] [Full Text] [Related]
8. FK506 for primary and rescue therapy following liver transplantation. Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570 [No Abstract] [Full Text] [Related]
9. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation. Walker RE; McCrindle BW; Coles JG; West LJ Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452 [No Abstract] [Full Text] [Related]
10. FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients. Goh BL; Tan SY Transplant Proc; 1998 Nov; 30(7):3594-5. PubMed ID: 9838575 [No Abstract] [Full Text] [Related]
11. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911 [No Abstract] [Full Text] [Related]
12. Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. Lipson DA; Palevsky HI; Kotloff RM; Edelman J Transplant Proc; 1998 Jun; 30(4):1505-7. PubMed ID: 9636612 [No Abstract] [Full Text] [Related]
13. Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. Hung CM; Jeng LB; Yeh CN; Hsieh CH; Lee WC; Chen MF Transplant Proc; 1998 Nov; 30(7):3589. PubMed ID: 9838572 [No Abstract] [Full Text] [Related]
14. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy. Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695 [No Abstract] [Full Text] [Related]
15. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439 [No Abstract] [Full Text] [Related]
16. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression. Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735 [No Abstract] [Full Text] [Related]
17. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. Marcus N; Khaghani A; Burke M; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460 [No Abstract] [Full Text] [Related]
18. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. Swenson JM; Fricker FJ; Armitage JM J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779 [TBL] [Abstract][Full Text] [Related]
19. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. Mehra MR; Uber PA; Park MH; Prasad AK; Scott RL Transplant Proc; 2001; 33(1-2):1606-7. PubMed ID: 11267438 [No Abstract] [Full Text] [Related] [Next] [New Search]